9-[5-(4-dibenzothiophen-2-yl-6-phenyl-1,3,5-triazin-2-yl)naphtho[2,1-b][1]benzofuran-8-yl]carbazole
C49H28N4OS — CID 164707515
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-[5-(4-dibenzothiophen-2-yl-6-phenyl-1,3,5-triazin-2-yl)naphtho[2,1-b][1]benzofuran-8-yl]carbazole
9-[5-(4-dibenzothiophen-2-yl-6-phenyl-1,3,5-triazin-2-yl)naphtho[2,1-b][1]benzofuran-8-yl]carbazole (PubChem CID 164707515) has the molecular formula C49H28N4OS and a molecular weight of 720.86 g/mol. Its IUPAC name is 9-[5-(4-dibenzothiophen-2-yl-6-phenyl-1,3,5-triazin-2-yl)naphtho[2,1-b][1]benzofuran-8-yl]carbazole.
Molecular Properties
| Compound Name | 9-[5-(4-dibenzothiophen-2-yl-6-phenyl-1,3,5-triazin-2-yl)naphtho[2,1-b][1]benzofuran-8-yl]carbazole |
|---|---|
| PubChem CID | 164707515 |
| Molecular Formula | C49H28N4OS |
| Molecular Weight | 720.86 g/mol |
| Exact Mass | 720.20 |
| IUPAC Name | 9-[5-(4-dibenzothiophen-2-yl-6-phenyl-1,3,5-triazin-2-yl)naphtho[2,1-b][1]benzofuran-8-yl]carbazole |
| SMILES | c1ccc(-c2nc(-c3ccc4sc5ccccc5c4c3)nc(-c3cc4oc5c(-n6c7ccccc7c7ccccc76)cccc5c4c4ccccc34)n2)cc1 |
| InChI | InChI=1S/C49H28N4OS/c1-2-13-29(14-3-1)47-50-48(30-25-26-44-37(27-30)34-18-8-11-24-43(34)55-44)52-49(51-47)38-28-42-45(35-19-5-4-15-31(35)38)36-20-12-23-41(46(36)54-42)53-39-21-9-6-16-32(39)33-17-7-10-22-40(33)53/h1-28H |
| InChIKey | PTLFGWNULKYMQR-UHFFFAOYSA-N |
| XLogP | 13.39 |
| TPSA | 56.74 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 55 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 720.86 |
| LogP ≤ 5 | 13.39 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164707515 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.